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Abstract
The biosynthesis of heparan sulfate (HS), an essential glycan in many organisms, involves an array
of specialized sulfotransferases. Here, we present a study aimed at engineering the substrate
specificity of different HS 3-O-sulfotransferase isoforms. Based on the crystal structures, we
identified a pair of amino acid residues responsible for selecting the substrates. Mutations at these
residues altered the substrate specificities. Our results demonstrated the feasibility of tailoring the
specificity of sulfotransferases to modify HS with desired functions.
Heparan sulfate (HS) plays a role in regulating embryonic development, inflammatory
response, and assisting viral/bacterial infections. HS is a highly sulfated polysaccharide that
contains repeating glucuronic acid (GlcUA, 1) or iduronic acid (IdoUA, 2) and glucosamine
units, each capable of carrying sulfo groups. Heparin, a commonly used anticoagulant drug, is
a specialized form of highly sulfated HS. The uniquely distributed sulfation pattern in HS is
believed to regulate its functional specificity 1,2. The wide range of functions attracts
considerable interest in exploiting HS or HS-like molecules for the development of anticancer,
antiviral, and better anticoagulant drugs 3. However, chemical synthesis of HS, especially those
larger than hexasaccharides, is extremely difficult. Employing HS biosynthetic enzymes,
specifically the HS sulfotransferases, for synthesizing HS has recently gained momentum 4,
5. The substrate specificities of HS sulfotransferases control the sulfation patterns in HS. Thus,
understanding the substrate recognition mechanism utilized by HS biosynthetic enzymes will
aid efforts in enzyme-based synthesis of HS with unique biological functions.
The HS 3-O-sulfotransferases (3-OST) family is composed of seven isoforms that synthesize
HS with specific biological consequences. These enzymes transfers a sulfo group (SO3) to a
3-OH position of a glucosamine unit. Each isoform of 3-OST transfers the sulfo group to the
glucosamine unit that is linked at the non-reducing end to either GlcUA (1)/IdoUA(2) unit (3-
OST-1-like activity), 2-O-sulfated iduronic acid (IdoUA2S, 3) unit (3-OST-3-like activity), or
a combination of both (3-OST-5-like activity) (Fig. 1)1. 3-OST-1-modified HS that is bound
by antithrombin regulates the blood coagulation cascade through intrinsic anticoagulant
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activity. 3-OST-3-modified HS is bound by herpes simplex virus type 1 glycoprotein D, serving
as an entry receptor for the virus. Interestingly, HS modified by 3-OST-5 endows both
anticoagulant activity and the ability to promote herpes simplex virus type 1 entry.
The crystal structure of human 3-OST-5 (h3-OST-5) presented here (Fig. 2A and Suppl. Table
1) exhibits high structural similarity to the previously reported structures of murine 3-OST-1
(r.m.s.d of 1.2Å over 248 Cα atoms) and human 3-OST-3 (r.m.s.d of 0.95Å over 257 Cα atoms)
(Suppl. Fig. 1). The core of these enzymes is comprised of an α/β motif, a structural feature
common among sulfotransferases and also found in certain protein kinases 6,7. Central to the
core is a P-loop like motif, termed the PSB-loop in sulfotransferases, which is involved in
binding to the sulfo donor, 3’-phosphoadenosine 5’-phosphosulfate (PAPS, 4). The proposed
position of the acceptor substrate, in a large open cleft running across the active site, is predicted
based on the crystal structure of 3-OST-3 in complex with a tetrasaccharide (Suppl. Fig 1)8.
The secondary and tertiary structures surrounding the core are quite similar in all three
enzymes, suggesting similar positioning of the acceptor polysaccharide substrate. Some small
structural variations are observed among isoforms as described in Suppl. Fig 1.
Based on the crystal structures, we attempted to engineer the specificity of the 3-OST-5 isoform
by selectively removing either 3-OST-1- or 3-OST-3-like activity from 3-OST-5 using a site-
directed mutagenesis approach. Initially, our efforts were focused on the catalytic site, where
both the acceptor and PAPS are in close proximity. However, these mutants are all catalytic
inactive, suggesting that these residues are required for catalytic function (Suppl. Table 2). We
next examined the structure of the 3-OST-5 substrate-binding cleft, in regions distal to the
active site, compared with the structures of 3-OST-1 and 3-OST-3. Two residues (Glu88 and
His271) in 3-OST-1, which might contact the polysaccharide unit toward the nonreducing end
of the sulfation site, appear to form a ‘gate’ across that end of the proposed substrate binding
cleft (Fig. 2B). These residues are located at the ends of β-strands 2 and 11. This ‘gate’ narrows
the cleft to a distance of 6.7Å. In 3-OST-3, however, the structurally corresponding residues
have very small side chains (Gly182 and Gly365), resulting in a wider cleft, with a distance of
14.2Å (Fig. 2C). 3-OST-5 is more similar in structure to 3-OST-3 in this region, where
Ser120 and Ala306 also give a wide (14.2Å) cleft (Fig. 2D).
The role of this gate in conferring substrate specificity for 3-OST-5 was investigated by
swapping the corresponding residues among isoforms. Three mutants were prepared, including
A306H, S120E and a double mutant S120E/A306H, converting them to amino acid residues
corresponding to those of 3-OST-1. We then determined the reactivity of the mutants to
different polysaccharide substrates (Table 1): N-sulfo heparosan (NSHP) consists mainly of a
disaccharide repeating unit of (–GlcUA-GlcNS-)n (Suppl. Fig. 2B); N-sulfo heparosan
iduronate 2-O-sulfate (NSHPI2S) predominantly consists of a disaccharide repeating unit of
(-IdoUA2S-GlcNS-)n (Suppl. Fig 2C). Choosing NSHP and NSHPI2S, we were able to
measure the contribution of the IdoUA2S unit to the substrate reactivity of the substrate. It is
known that 3-OST-3-like activity sulfates the glucosamine that is linked to an IdoUA2S unit
at the nonreducing end (Fig. 1). HS is a natural substrate and is structurally more complex,
consisting of six different disaccharides units (Suppl. Fig 2D). All three 3-OST-5 mutants
displayed reduced reactivity to NSHPI2S (4 to 12-fold decreased compared to that of wild type
enzyme, Table 1), while retaining the same reactivity to NSHP, suggesting that Ser120 and
Ala306 are required for those substrates carrying the IdoUA2S unit. Our results also suggest
that mutation of the gate residues greatly reduces 3-OST-3-like activity of 3-OST-5 enzyme.
“Gate” residues of 3-OST-1 were replaced by the gate residues of 3-OST-3 to create the
following mutants: E88G, H271G and H271G/E88G. We observed that both 3-OST-1 H271G
and 3-OST-1 H271G/E88G had increased reactivity for NSHPI2S (17- and 9-fold,
respectively) (Table 1). Furthermore, both mutants had increased reactivity to NSHP. Our data
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suggest that 3-OST-1 mutants H271G and H271G/E88G retain 3-OST-1 activity and have
acquired enhanced 3-OST-3-like activity, which is equivalent to the substrate specificity of 3-
OST-5. Indeed, both NSHP and NSHPI2S are good substrates for 3-OST-5 (Table 1). Thus,
the gate structure in 3-OST-1 also regulates the substrate specificity. We noted that 3-OST-1
E88G displayed no changes in reactivity to either NSHPI2S or NSHP.
Replacing the gate residues of 3-OST-1 with serine (E88S), alanine (H271A) or both (E88S/
H271A), which are the corresponding residues in 3-OST-5, had similar effect on reactivity to
the polysaccharide substrates as the 3-OST-1 mutants (H271G and E88G/H271G) (Suppl.
Table 3). Mutantions at the gate residues were prepared for 3-OST-3, but did not have
significant effects on substrate specificity, suggesting that there may be other factors
contributing to substrate selection in 3-OST-3 (Suppl. Table 3).
Although we did not observe significant differences in the substrate reactivity among 3-OST
mutants to HS, the products displayed different binding profiles to antithrombin (AT) and
herpes simplex virus glycoprotein D (gD) (Table 1). HS modified by 3-OST-5 mutants S120
E, A306H, and S120E/A306H increased binding to AT from 15% to 25%, 22% and 25%,
respectively. In contrast, the percentage of gD-binding HS was decreased among the HS
modified by the mutant proteins (from 13.4% to 5.7–7.5 %). For 3-OST-1 mutants, both H271G
and E88G/H271G showed a significant decrease in the binding to AT (from 44% to about
18%), and a modest increase in gD-binding HS for 3-OST-1 mutants H271G and E88G/H271G
was observed (from 6.4 % to 8–11%). 3-OST-3 mutants showed no significant difference in
the synthesis of AT- and gD-binding HS. The decrease in gD binding by products of 3-OST-3
mutants G365H G182E/G365H was likely due to substantially decreased 3-O-sulfotransferase
activity (Suppl. Table 3). Disaccharide composition analysis of HS [35S]sulfated by 3-OST
mutants confirmed the transformation of 3-OST isoforms (Suppl. Table 4 and Suppl Fig 3).
Results from kinetic analysis suggested that mutation did not alter the enzyme catalytic
efficiency (Suppl. Table 5).
Our results have given insight into the mechanism used by 3-OST isoforms, especially for 3-
OST-5 and 3-OST-1, to determine the substrate specificity. It appears that the enzyme employs
two sites, namely the catalytic site and the gate, to select the appropriate polysaccharide
substrate as depicted in Suppl. Fig. 4. The catalytic site interacts with the acceptor glucosamine
unit (S-site) as well as one saccharide unit to either side (+1 site and −1 site). The catalytic
sites are highly homologous among isoforms, and the amino acid residues involved in binding
to the substrate are essential for 3-O-sulfotransferase activity. However, the entire substrate
recognition motif that dictates different selectivity among the isoforms likely incorporates at
least five sugar units (expanding from −3 site to +1 site, Suppl. Fig 4). Although the exact
structure of the substrate recognized by this motif is unknown, the gate residues appear to be
involved in the selective process, discriminated for or against the presence of IdoUA2S (Suppl.
Fig. 4). Alterations of the gate residues could allow the isoform to gain substrate selectivity by
replacing them with larger amino acid residues, as demonstrated for 3-OST-5 S120E, 3-OST-5
A306H, and 3-OST-5 S120E/A306H. Alternatively, replacing the gate residues of 3-OST-1
with smaller amino acids, such as glycine, resulted in loss of substrate selectivity, as
demonstrated for 3-OST-1 H271G and 3-OST-1 E88G/H271G.
One explanation for the substrate selectivity for IdoUA2S is based on sugar conformations
within the chain. It is known that glucuronic acid and glucosamine are stably found in
the 4C1, while IdoUA2S is present in both 1C4 and 2S0 conformations9. The conformational
flexibility of the IdoUA2S residue, compared to that of GlcUA, can contribute to local changes
in polysaccharide chain conformation, and altered distribution of sulfate groups. Such
difference could enhance binding selection by different 3-OST isoforms. The overall charge
from the sulfo groups may also play a role in binding. However, the precise involvement of
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charge-charge interactions is currently unknown. Additional factors may also be involved in
fine tuning the synthesis of the polysaccharides with specific functions because the level of
AT-binding HS in the products modified by 3-OST-5 mutants is not as high as that made by
3-OST-1 wild type protein.
Because the substrate specificity of HS sulfotransferases is inherently high, it is believed that
the number of the saccharide structures generated by naturally occurring enzymes is limited.
Substrate specificity engineering could expand the scope of the saccharide structures generated
by a given enzyme. The structural diversity of the polysaccharides could be further expanded
by utilizing polysaccharide substrates with different sulfation patterns. Our findings may
someday be utilized for enzymatic synthesis of HS libraries or to prepare more homogenous
polysaccharides for developing polysaccharide-based drugs4.
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Fig. 1. The substrate specificity of 3-OST isoforms and the biological functions of the HS modified
by different 3-OST isoforms
Different 3-OST isoforms transfer a sulfo group (SO3) to the 3-OH position of glucosamine
present in different disaccharide units. 3-OST-1-like activity transfers a sulfo group to the
glucosamine residue that is either linked to the glucuronic acid (GlcUA) or the iduronic acid
(IdoUA), yielding the product containing disaccharides −GlcUA-GlcNS3S±6S- or −IdoUA-
GlcNS3S±6S-. HS modified by 3-OST-1 binds to antithrombin and has the anticoagulant
activity. The 3-OST-3-like activity transfers a sulfo group to the glucosamine residue that is
linked to the 2-O-sulfated iduronic acid (IdoUA2S) to yield the product containing the
disaccharide of −IdoUA2S-GlcNR±3S6S- (R = −H or −SO3−). HS modified by 3-OST-3 binds
to herpes simplex virus type 1 gD and serves as an entry receptor for herpes simplex virus type
1. 3-OST-5 has both 3-OST-1-like and 3-OST-3-like activities, thus, the HS modified by 3-
OST-5 binds to both antithrombin and gD and has both the anticoagulant activity and serves
as an entry receptor for herpes simplex virus.
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Fig. 2. Structural characterization of 3-O-sulfotransferase isoforms 1, 3, and 5
A. Ribbon diagram of the crystal structure of human 3-OST-5 with bound PAP (5). Secondary
structural elements are shown as α-helices (blue, labeled as A#), β-strands (green, labeled as
B#), and random coils (yellow). The bound PAP molecule is drawn as ball-and-stick (cyan).
This figure was created using Molscript10 and Raster3D11. Panels B–D show substrate
recognition by 3-OST enzymes via a gating structure. The bound PAP molecule is shown as
ball-and-stick, though only the phosphate moieties (orange) are visible due to their buried
location. Amino acid residues are shown on the surface in red, and are labeled in white text.
Distances measured are shown as black dotted lines, and are labeled in white. The position of
the substrate binding cleft is shown as a dashed green arrow. B. Key amino acid residues
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forming a ‘gate’ on the nonreducing end of the substrate binding cleft of m3-OST-1. C.
Structurally corresponding gate residues in h3-OST-3. The bound tetrasaccharide substrate
(ΔUA2S-GlcNS6S-IdoUA2S-GlcNS6S, 6) is drawn as ball-and-stick, with the glucosamine
residue to be sulfated circled in yellow. D. Structurally corresponding gate residues in h3-
OST-5. These molecular surfaces were generated using PyMOL12.
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